6-Methylspiro[chroMan-2,4'-piperidin]-4-one hcl
![]() |
- $167 - $611
- Product name: 6-Methylspiro[chroMan-2,4'-piperidin]-4-one hcl
- CAS: 753424-31-6
- MF: C14H17NO2
- MW: 231.29
- EINECS:
- MDL Number:MFCD09262408
- Synonyms:6-Methylspiro[chroMan-2,4'-piperidin]-4-one hcl;Spiro[2H-1-benzopyran-2,4'-piperidin]-4(3H)-one, 6-Methyl-;6-Methylspiro[chromene-2,4-piperidin]-4(3H)-one;6-methylspiro[chroman-2,4'-piperidin]-4-one;6-Methyl-Spiro[Chromene-2,4-Piperidin]-4-(3H)-One(WXC00075);6-Methylspiro[chromane-2,4'-piperidin]-4-one;6-methylspiro[chromane-2,4'-piperidin]-4-one;6-Methylspiro[chroMan-2,4'-piperidin]-4-one hcl
3 prices
Selected condition:
Brand
- Crysdot
- Sigma-Aldrich
- TRC
Package
- 250mg
- 1g
- ManufacturerCrysdot
- Product numberCD11062302
- Product description6-Methylspiro[chroman-2,4'-piperidin]-4-onehydrochloride 97%
- Packaging1g
- Price$611
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberPH017754
- Product description6-Methylspiro[chroman-2,4′-piperidin]-4-one AldrichCPR
- Packaging250mg
- Price$167
- Updated2023-06-20
- Buy
- ManufacturerTRC
- Product numberM224783
- Product description6-Methylspiro[chroman-2,4''-piperidin]-4-one
- Packaging250mg
- Price$285
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11062302 | 6-Methylspiro[chroman-2,4'-piperidin]-4-onehydrochloride 97% | 1g | $611 | 2021-12-16 | Buy |
Sigma-Aldrich | PH017754 | 6-Methylspiro[chroman-2,4′-piperidin]-4-one AldrichCPR | 250mg | $167 | 2023-06-20 | Buy |
TRC | M224783 | 6-Methylspiro[chroman-2,4''-piperidin]-4-one | 250mg | $285 | 2021-12-16 | Buy |
Properties
Boiling point :408.9±45.0 °C(Predicted)
Density :1.18±0.1 g/cm3(Predicted)
pka :10.22±0.20(Predicted)
form :solid
Density :1.18±0.1 g/cm3(Predicted)
pka :10.22±0.20(Predicted)
form :solid
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|